These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18853387)

  • 1. Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance.
    Stringer R; Nicklin PL; Houston JB
    Xenobiotica; 2008 Oct; 38(10):1313-29. PubMed ID: 18853387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.
    Brown HS; Griffin M; Houston JB
    Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance.
    Huang L; Berry L; Ganga S; Janosky B; Chen A; Roberts J; Colletti AE; Lin MH
    Drug Metab Dispos; 2010 Feb; 38(2):223-31. PubMed ID: 19875499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
    Riley RJ; McGinnity DF; Austin RP
    Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of metabolic clearance using cryopreserved human hepatocytes: kinetic characteristics for five benzodiazepines.
    Hallifax D; Rawden HC; Hakooz N; Houston JB
    Drug Metab Dispos; 2005 Dec; 33(12):1852-8. PubMed ID: 16174807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
    Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes.
    Ito K; Houston JB
    Pharm Res; 2004 May; 21(5):785-92. PubMed ID: 15180335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance.
    Foster JA; Houston JB; Hallifax D
    Xenobiotica; 2011 Feb; 41(2):124-36. PubMed ID: 21058916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-specific binding of compounds in
    Gardner I; Xu M; Han C; Wang Y; Jiao X; Jamei M; Khalidi H; Kilford P; Neuhoff S; Southall R; Turner DB; Musther H; Jones B; Taylor S
    Xenobiotica; 2022 Aug; 52(8):943-956. PubMed ID: 36222269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of metabolic clearance using fresh human hepatocytes: comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines.
    Hallifax D; Galetin A; Houston JB
    Xenobiotica; 2008 Apr; 38(4):353-67. PubMed ID: 18340561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro.
    Naritomi Y; Terashita S; Kagayama A; Sugiyama Y
    Drug Metab Dispos; 2003 May; 31(5):580-8. PubMed ID: 12695346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs.
    Hallifax D; Houston JB
    J Pharm Sci; 2012 Aug; 101(8):2645-52. PubMed ID: 22700322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
    Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.
    Soars MG; Burchell B; Riley RJ
    J Pharmacol Exp Ther; 2002 Apr; 301(1):382-90. PubMed ID: 11907196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds.
    Sohlenius-Sternbeck AK; Afzelius L; Prusis P; Neelissen J; Hoogstraate J; Johansson J; Floby E; Bengtsson A; Gissberg O; Sternbeck J; Petersson C
    Xenobiotica; 2010 Sep; 40(9):637-49. PubMed ID: 20624033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes.
    Lu C; Li P; Gallegos R; Uttamsingh V; Xia CQ; Miwa GT; Balani SK; Gan LS
    Drug Metab Dispos; 2006 Sep; 34(9):1600-5. PubMed ID: 16790553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-Human Predictions of Hepatic Clearance for Drugs With the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding Kinetics.
    Poulin P
    J Pharm Sci; 2024 Aug; 113(8):2641-2650. PubMed ID: 38796154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.